Current Management Strategies of the Postmenopausal Patient with Sexual Health Problems
- 1 March 2007
- journal article
- review article
- Published by Oxford University Press (OUP) in The Journal of Sexual Medicine
- Vol. 4 (Supplement) , 235-253
Abstract
Introduction: Sexual health concerns of menopausal women include decreases in sexual interest, arousal, lubrication, and orgasm, and increases in sexual pain, all of which may be associated with distress. Aim: To review a step-care progression of sexual healthcare management: identification of the sexual health problem; education of the patient and the partner; modification of reversible causes; first-line therapies consisting of devices and medications; and second-line therapies with more invasive treatments including surgery. Methods: The healthcare provider is presented with a clinical diagnosis and treatment paradigm that engages mind, body, and relationship issues proceeding step-wise in a rational and cost-effective fashion. Main Outcome Measure: Literature review in women's sexual health. Results: Women's health, including sexual health, is a fundamental human right. Supported by evidence-based data, a step-care approach to diagnosis and management of women with sexual health problems is advised. Multidisciplinary interventions should be considered as needed. Identification of sexual health concerns engages diagnostic components of psychologic consultation, history, physical examination, and laboratory testing as appropriate. Key to clinical assessment is the detailed sexual, medical, and psychosocial history. No agreement exists on necessary laboratory tests. Patient (and partner) education improves understanding of treatment options and expectations, and promotes a trusting patient–physician partnership. Modification of reversible causes includes sex therapy, lubricants, altering medications, modifying lifestyle and physical therapy for pelvic floor disorders. First-line therapies should be administered based upon diagnosis, needs, expectations, risks, benefits, and cost, and include medical devices and drugs such as hormones, vasoactive agents, dopamine agonists, topical steroids, anti-infectious agents, and analgesic agents. Second-line therapies, such as surgery, are initiated upon failure, insufficient response, or adverse side effects associated with one or more of the first-line therapies or patient preference. Conclusions: For postmenopausal women with sexual dysfunction, a rational clinical management strategy begins with treatment options that are most reversible and least invasive and costly.Keywords
This publication has 72 references indexed in Scilit:
- What Can Prevalence Studies Tell Us About Female Sexual Difficulty and Dysfunction?The Journal of Sexual Medicine, 2006
- A Methodology Study to Develop and Validate a Screener for Hypoactive Sexual Desire Disorder in Postmenopausal WomenThe Journal of Sexual Medicine, 2006
- Hypoactive Sexual Desire Disorder in Menopausal Women: A Survey of Western European WomenThe Journal of Sexual Medicine, 2006
- Sexual Activity, Prevalence of Sexual Problems, and Associated Help-Seeking Patterns in Men and Women Aged 40–80 Years in Korea: Data from the Global Study of Sexual Attitudes and Behaviors (GSSAB)The Journal of Sexual Medicine, 2006
- Biological and Psychosocial Pathophysiology of Female Sexual Dysfunction During the Menopausal TransitionThe Journal of Sexual Medicine, 2005
- Confronting the Challenges: Epidemiological Study of Female Sexual Dysfunction and the MenopauseThe Journal of Sexual Medicine, 2005
- The Impact of Aging on Sexual Function and Sexual Dysfunction in Women: A Review of Population-Based StudiesThe Journal of Sexual Medicine, 2005
- Assessment and Management of Women's Sexual Dysfunctions: Problematic Desire and ArousalThe Journal of Sexual Medicine, 2005
- Clinical Biologic Pathophysiologies of Women's Sexual DysfunctionThe Journal of Sexual Medicine, 2005
- Sexual Dysfunction in the United StatesJAMA, 1999